Merger & Acquisition News

ATLANTA--(BUSINESS WIRE)--This partnership strongly supports Engle Martin & Associates commitment to strengthening its service in the London and E&S Lines marketplace....

NEW YORK--(BUSINESS WIRE)--Blue Wolf Capital Partners LLC (“Blue Wolf”), a New York-based private equity firm, today announced the sale of StateServ Medical (“StateServ”) to WindRose Health Investors, LLC (“WindRose”). Terms of the transaction were not disclosed. Based in Mesa, Arizona, StateServ is the leading durable medical equipment benefit management company supporting hospices and other post-acute care providers in the United States. Since Blue Wolf’s investment in the company in August 2...

SAINT PAUL, Minn.--(BUSINESS WIRE)--Altus Capital Partners' MGC Diagnostics acquires Lemon Medical, GmbH, a medical technology company, headquartered in Hammelburg, Germany...

BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that it has completed the previously announced acquisition of Novitium Pharma, a privately held, New Jersey-based pharmaceutical company with development, manufacturing, and commercialization capabilities. “Today marks a major milestone for ANI and the many patients who rely on our high-quality, cost-effective medications. With the completion of this acquisition, we bring on board a w...

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck Completes Acquisition of Acceleron Pharma Inc....

CALGARY, Alberta--(BUSINESS WIRE)--High Tide Inc. (“High Tide” or the “Company”) (TSXV: HITI) (Nasdaq: HITI) (FRA: 2LYA), a leading retail-focused cannabis company with bricks-and-mortar as well as global e-commerce assets, is pleased to announce that it is taking another step towards solidifying itself as a major player within the global marketplace for hemp-derived CBD products, by entering into a definitive agreement (the “Acquisition Agreement”) pursuant to which High Tide will acquire 80%...

MONTREAL--(BUSINESS WIRE)--In March 2019, Medisca Pharmaceutique Inc. acquired Samix GmbH, a German manufacturer of compounding systems for use in pharmacies. Following such acquisition, Medisca supported Samix in its several legal disputes with Samix’ main competitor, the GAKO group comprised of inter alia GAKO Konietzko GmbH and GAKO International GmbH (collectively, “old Gako”), which have since become insolvent. In course of the insolvency proceedings, old GAKO’s business was acquired by Fa...

ST. GALLEN, Switzerland & PALMA, Spain & ZURICH--(BUSINESS WIRE)--Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Vifor Pharma has announced the acquisition of Sanifit Therapeutics, a Spanish clinical-stage cardio-renal biopharmaceutical company focused on treatments for end-stage kidney disease patients with progressive vascular calcification disorders, and Inositec AG, a Swiss company, developing first-in-class non-dialysis treatments for soft tissue and vascular calcification dis...

MONROVIA, Calif., HONG KONG & BOSTON--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, and Zenas BioPharma (“Zenas”), a global biopharmaceutical company based in the USA and China committed to the development and delivery of immune-based therapies, today announced that Zenas has acquired from Xencor exclusive worldwide rights to develop, manufact...

ATLANTA--(BUSINESS WIRE)--Ciner Enterprises Inc. (CEI), a wholly owned subsidiary of We Soda Ltd of London, UK, has signed a definitive agreement to sell 60% of Ciner Resources Corporation (CRC) to Sisecam Chemicals USA Inc., a wholly owned subsidiary of Turkiye Sise ve Cam Fabrikalari A.S. of Istanbul, Turkey. CRC owns an approximately 72% limited partner interest in Ciner Resources LP (NYSE: CINR) (“Ciner Resources” or the “Partnership”), as well as its 2% general partner interest and related...